Anna Bogstedt

Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.

Harald Hampel, Michael Ewers, Katharina Bürger et al. · PubMed · 2009 · 306 citations

Neuropsychiatry, Neurochemical Biomarkers, Tau Protein +19

Lithium Trial in Alzheimer's Disease

Harald Hampel, Michael Ewers, Katharina Bürger et al. · The Journal of Clinical Psychiatry · 2009 · 283 citations

Neuropsychiatry, Neurochemical Biomarkers, Tau Protein +17

Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia

Erika Bereczki, Paul T. Francis, David Howlett et al. · Alzheimer s & Dementia · 2016 · 168 citations · Full text

AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics

Susanna Eketjäll, Juliette Janson, Karin Kaspersson et al. · Journal of Alzheimer s Disease · 2016 · 128 citations · Full text

Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo

Darren J. Schofield, Lorraine Irving, Laura Calò et al. · Neurobiology of Disease · 2019 · 110 citations · Full text